Bone marrow transplantation-related thrombotic microangiopathy (BMT-TMA) is a severe complication partly suspected on the evidence of a microangiopathic haemolysis. Microscopic schistocyte ...

Shugart, who began in her new role on July 1, 2025, will fully assume all executive management responsibilities of current TMA CEO Celia T. Besore, MBA, FASAE, CAE, upon her retirement on July 18, ...

In patients with HSCT-TMA, the lectin pathway is activated. 10 Mannan-binding lectin-associated serine protease-2 (MASP-2) is the effector enzyme of the lectin pathway and an activator of the ...